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Aminophenyl-containing pyridines are of interest for their further 
functionalization leading to new heterocyclic systems.1 Moreover, 
they possess biological activity.2
On the other hand, 2-(het)arylpyridines are common ligands for 
various metal cations, some of them having found use as phos-
phorescent labels for bioimaging.3 Aminoaryl-substituted deriva-
tives of 2-(het)arylpyridines are good substrates for this purpose, 
as they can be readily converted into isothiocyanate ones by treat-
ment with thiophosgene just before the bioconjugation.4 For the 
effective bioimaging these functional groups are usually separated 
from the metal chelating site, e.g., by aromatic sub stituent(s).
A number of methods for the synthesis of aminophenyl-
pyridines are described in literature.5,6 However, only one example 
based on 1,2,4-triazine methodology for the synthesis of amino-
phenyl-containing pyridine7 is described, although this approach 
has been recognized as a prospective tool to access various 
pyridines.8 The key advantage of this methodology is the possi-
bility for one-step derivatization of C3 and/or C4 positions in 
newly formed pyridine ring simply by varying the dienophile 
and/or the the substitution pattern in the starting 1,2,4-triazines. 
Herein, we describe an application of this methodology to access 
aminophenyl-containing pyridines.
2-(Het)arylpyridines bearing aminophenyl substituent at C5 
position were the targets of our study since cyclometalled com-
plexes of similar ligands possess an intriguing photophysical 
properties,9 therefore these complexes can be promising chromo-
phores for the photoluminescent imaging of biomolecules. In 
addi tion, the phosphorescent label based on platinum complex of 
similar ligand containing carboxylic group for further con juga-
tion with biomolecule was reported.10
For the synthesis of parent 1,2,4-triazines two previously 
described methods were used.11 Interaction of 2-bromo-3'-nitro-
acetophenone 1 with two equivalents of carboxhydrazides 2 
or condensation of isonitrosoacetophenone hydrazones 3 with 
pyridine-2-carboxaldehyde 4 afforded triazines 5a–e (Scheme 1, 
for details, see Online Supplementary Materials).
Comparative studies of photophysical properties of platinum 
complexes of 5-aryl-2-(2-thienyl)pyridines and the corresponding 
cyclopenteno[c]pyridines demonstrated that the latter exhibit 
higher values for both the luminescence lifetime and quantum 
yield,9(a) therefore they are more preferable for application as 
phosphorescent labels for bioimaging. To obtain cyclopenteno-
[c]pyridines from 1,2,4-triazines 5, 1-morpholinocyclopentene 
should be used as the dienophile in the aza-Diels–Alder reac-
tion.
The target cyclopenteno[c]pyridines 6 were prepared as de-
scribed12 by heating 1,2,4-triazines 5a–d with an excess of enamine 
at 200 °C without solvent under argon atmosphere. Unexpectedly, 
the processing not only led to the complete formation of the cyclo-
pentenopyridine system, but also caused the reduction of nitro 
group into the amino one (Scheme 2).† It should be noted that 
for the full conversion of 5, longer reaction time compared to the 
original procedure was required.
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Unexpected reduction of the nitro group to the amino one during aza-Diels–Alder reaction between (3-nitrophenyl)-1,2,4-triazines and 
1-morpholinocyclopentene (neat, 200 °C, argon) occurred to furnish 4-(3-aminophenyl)-6,7-dihydro-5H-cyclopenta[c]pyridines.
†
 Synthesis of 6,7-dihydro-5H-cyclopenteno[c]pyridines 6, 9 and 10 (typical 
procedure). Mixture of corresponding triazine 5, 7 or 8 (2 mmol) and 
1-morpholinocyclopentene (1.6 ml, 10 mmol) was stirred at 200 °C under 
argon atmosphere for 2 h, after that two more portions of enamine 
(2×0.64 ml, 2×4 mmol) were added and the reaction mixture was stirred 
at 200 °C for 1 h after each portion. The mixture was cooled to room 
temperature and placed as is on chromatographic column (SiO2) and 
eluted with chloroform. Combined fractions containing product (Rf = 0.2) 
were concentrated under reduced pressure to ca. 10 ml. The product was 
extracted with 3 n hydrochloric acid (3×20 ml). Sodium hydroxide 
pellets were added to hydrochloric acid extract upon cooling to adjust 
pH to 12 and the product was extracted with dichloromethane (3×20 ml). 
The combined organic extracts were dried with anhydrous sodium sulfate, 
filtered and solvent was removed under reduced pressure. Analytical 
sample was recrystallized from ethanol.
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Scheme 1 Reagents and conditions: i, AcONa, EtOH–AcOH (3:1), 105 °C, 
12 h; ii, ethanol, 20 °C, 10 h, then AcOH, 118 °C, 5 min.
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Structures of products 6 were proved by 1H and 13C NMR 
data (a significant upfield shift of signals of hydrogen atoms 
of phenyl ring was observed). The presence of amino group in 
compounds 6 was confirmed by 2D COSY (1H–15N) experiment 
carried out for product 6c. Thus, the interaction between nitrogen 
atom (54 ppm) and hydrogen atoms (3.78 ppm) was observed in 
2D COSY (1H–15N) spectra.
Interestingly, isomeric 4-nitrophenyl-1,2,4-triazine 5e gave 
neither nitro- nor aminophenyl-substituted cyclopenteno[c]pyri-
dine 6e and only a complex mixture of unidentified products was 
formed (Scheme 3).
In order to investigate the influence of the position of 3-nitro-
phenyl substituent onto the reaction outcome we tested other 
3-nitrophenyl-substituted 1,2,4-triazines11(a),13 7 and 8, which gave 
amino pyridines 9 and 10 in satisfactory yields (Scheme 4).†
Presumably enamine acts as a reducing agent in this trans-
formation, with the inert atmosphere being an essential factor. 
Mechanism of the reaction is under study. Some literature data14 
support our hypothesis, i.e. the reaction of 2,6-bis[6-(4-nitro-
phenyl)-1,2,4-triazin-3-yl]pyridine with excess of enamine in 
boiling 1,4-dioxane in air occurred only as a 1,2,4-triazine-to-
pyridine transformation with nitro group remaining untouched. 
Refluxing of nitrobenzenes in neat 1-pyrrolidinocyclohexene (more 
powerful reducing agent) caused the complete reduction of the 
nitro group. Position of the nitro group in the aromatic substituent 
in 1,2,4-triazine system is also important. In particular, in case 
of 4-nitrophenyl-1,2,4-triazines (e.g., 5e) no 4-aminophenyl-
pyridines were isolated. Such a low reactivity can be explained 
by the conjugation between nitro group and 1,2,4-triazine system 
as an electron-withdrawing substituent. Apparently, in case of 
3-nitrophenyl substituent conjugation between nitro group and 
1,2,4-triazine core is weaker.
In conclusion, we have suggested a good method for the 
conversion of 3-nitrophenyl-substituted 1,2,4-triazines into aryl-
6,7-dihydro-5H-cyclopenteno[c]pyridines 6a–d, 9, 10 bearing 
3-aminophenyl moiety, which seems promising for their further 
conjugation with biomolecules. This method is advantageous 
in view of the little number of steps and simplicity of the pro-
cessing.
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Scheme 4 Reagents and conditions: i, ethanol, 78 °C, 2 h; ii, ethanol–AcOH 
(3:1), 90 °C, argon atmosphere, 10 h; iii, 1-morpholinocyclopentene, neat, 
200 °C, argon atmosphere, 4 h.
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 4-(3-Aminophenyl)-1-phenyl-6,7-dihydro-5H-cyclopenteno[c]pyridine 
6a. Yield 315 mg (1.1 mmol, 55%), mp 144–146 °C. 1H NMR (CDCl3) 
d: 2.08 (m, 2 H, 6-CH2), 3.06 (t, 2 H, 7-CH2, 3J 7.2 Hz), 3.17 (t, 2 H, 
5-CH2, 3J 7.2 Hz), 3.78 (br. s, 2 H, NH2), 6.73 [m, 1H, H-4 (3-NH2Ph)], 
6.80 [dd, 1H, H-2 (3-NH2Ph), J 1.8 Hz], 6.89 [m, 1H, H-6 (3-NH2Ph)], 
7.26 [dd, 1H, H-5 (3-NH2Ph), J 8.0 Hz], 7.41 (m, 1H, Ph), 7.48 (m, 2 H, 
Ph), 7.79 (m, 2 H, Ph), 8.54 (s, 1H, H-3). 13C NMR (CDCl3) d: 25.9, 
33.0, 33.1, 114.4, 115.1, 119.0, 128.2, 128.3, 128.5, 129.5, 132.8, 137.4, 
139.0, 140.1, 146.7, 147.1, 152.5, 152.8. ESI-MS, m/z: 287.16 (M + H)+ 
(required 287.15). Found (%): C, 83.60; H, 6.27; N, 9.69. Calc. for 
C20H18N2 (%): C, 83.88; H, 6.34; N, 9.78.
 3-(3-Aminophenyl)-1-(2-pyridyl)-6,7-dihydro-5H-cyclopenteno[c]-
pyridine 9. Yield 270 mg (0.94 mmol, 47%), mp 108–110 °C. 1H NMR 
(CDCl3) d: 2.13 (m, 2 H, 6-CH2), 3.00 (t, 2 H, 7-CH2, J 7.6 Hz), 3.45 (t, 
2 H, 5-CH2, J 7.2 Hz), 3.75 (br. s, 2 H, NH2), 6.73 [m, 1H, H-4 (3-NH2Ph)], 
7.26 [m, 2 H, H-5 (3-NH2Ph), H-5 (Py)], 7.45 [m, 1H, H-6 (3-NH2Ph)], 
7.51 [dd, 1H, H-2 (3-NH2Ph), J 2.0 Hz], 7.63 (s, 1H, H-4), 7.81 [ddd, 1H, 
H-4 (Py), J 7.8, 7.8 and 2.0 Hz], 8.43 [dd, 1H, H-3 (Py), J 7.8 and 1.0 Hz], 
8.69 [dd, 1H, H-6 (Py), J 4.8 and 2.0 Hz]. 13C NMR (CDCl3) d: 25.1, 
32.8, 33.0, 113.8, 115.4, 116.6, 117.3, 122.7, 123.2, 129.5, 136.3, 138.0, 
141.0, 146.8, 148.4, 151.2, 154.6, 156.7, 158.8. ESI-MS, m/z: 288.15 
(M + H)+ (required 288.15). Found (%): C, 79.22; H, 5.80; N, 14.72. Calc. 
for C19H17N3 (%): C, 79.41; H, 5.96; N, 14.62.
 For synthesis of compounds 5, 7 and 8 and characteristics of compounds 
6b–d, 7, 8 and 10, see Online Supplementary Materials.
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